These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20975455)

  • 1. Lower long-term immunogenicity of mumps component after MMR vaccine.
    De Laval F; Haus R; Spiegel A; Simon F
    Pediatr Infect Dis J; 2010 Nov; 29(11):1062-3; author reply 1063. PubMed ID: 20975455
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study.
    Avijgan M; Hafizi M; Moghni M; Kheiri S; Esteghamati A; Sarikhani S
    East Afr J Public Health; 2011 Jun; 8(2):88-91. PubMed ID: 22066292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemics in vaccinated persons. Do adults need a mumps booster vaccination? (interview by Dr. Judith Neumaier)].
    Mankertz A
    MMW Fortschr Med; 2008 Jun; 150(23):7. PubMed ID: 18578069
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mumps control today.
    Quinlisk MP
    J Infect Dis; 2010 Sep; 202(5):655-6. PubMed ID: 20662719
    [No Abstract]   [Full Text] [Related]  

  • 7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.
    Avijgan M; Habibian R; Kheiri S
    East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
    St Sauver JL; Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Hum Immunol; 2005 Jul; 66(7):788-98. PubMed ID: 16112026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS; Han HW; Go U; Chung HW
    Vaccine; 2004 Dec; 23(3):290-7. PubMed ID: 15530670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing outbreak of mumps infection in Oban, Scotland, November 2010 to January 2011.
    Walker J; Huc S; Sinka K; Tissington A; Oates K
    Euro Surveill; 2011 Feb; 16(8):. PubMed ID: 21371413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: comparisons with injected MMR.
    Diaz-Ortega JL; Bennett JV; Castaneda D; Vieyra JR; Valdespino-Gomez JL; de Castro JF
    Vaccine; 2010 Jan; 28(3):692-8. PubMed ID: 19861187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence in young adults 1 year after MMR immunization by aerosol or by subcutaneous route.
    Díaz-Ortega JL; Bennett JV; Castañeda D; Martinez D; de Castro JF
    Vaccine; 2010 Oct; 28(44):7228-32. PubMed ID: 20800111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.